IoFlow, a company specializing in wearable insulin pumps, has hit the upper price limit.


As of 2:50 PM on the 18th, IoFlow is trading on the KOSDAQ market at 13,650 KRW, up 3,150 KRW (30%) from the previous day.


IoFlow's main products consist of a smart wearable system targeting patients who require insulin infusion within the diabetes market, one of the representative chronic wasting diseases.


Hot Picks Today

"If It's Uncomfortable, They Cut Ties": Three Out of Five U.S. Gen Z Have Broken Off Contact With Family or Friends in the Past Year "If It's Uncomfortable, They Cut Ties": Three O...

IoFlow experienced a decline for eight consecutive trading days from the 4th to the 14th, closed flat on the 17th, and then rose to the upper price limit the following day.


한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing